Best Biopharma Outsourcing Companies in Auvergne Rhone Alpes, France
The 32 best Biopharma Outsourcing companies in Auvergne Rhone Alpes, France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Isaltis.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Auvergne Rhone Alpes
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Isaltis Company developing and manufacturing high purity mineral salts for a wide range of industries | $55M | 139 mo ago | 160 | 2011 | — | WordPressMySQLPHP+12 | — | — |
| 2 | Kayentis Provider of electronic clinical outcome assessment solutions for clinical trials | $36M | 43 mo ago | 12 | 2003 | Philippe Berna Founder | WordPressMySQLPHP+25 | — | — |
| 3 | Biose Provider of therapeutic macrobiotic ranges for human health | $34M | 75 mo ago | 2 | 2013 | — | WordPressMySQLPHP+19 | 14 patents Mucoadhesive vaginal drug delivery systems for sustained antifungal therapy | — |
| 4 | biose industrie Developer of drugs based on live microorganisms | $34M | 75 mo ago | 227 | 1951 | Stanislas Desjonqeères CEO | — | — | — |
| 5 | GenOway Provider of transgenic rodent models and customized cell lines for preclinical development | $12M | 82 mo ago | 124 | 1999 | — | WebflowMatomo AnalyticsGoogle Analytics+16 | 15 patents Conditional knockout/knockin animal models and cloning vectors for genetic engineering | — |
| 6 | Mapi Group Real world evidence studies and post-approval research services | $8M | 256 mo ago | 750 | 1990 | — | — | — | — |
| 7 | Novasep CDMO offering its services for small molecules and biologics, and specializing in chromatography based… | $4M | 93 mo ago | 798 | 1995 | Pierre Lunel CEO | — | 52 patents Advanced multi-column gradient chromatography and isotope enrichment separation technologies | — |
| 8 | TransCure bioServices Developer of humanized animal models for preclinical studies | $4M | 52 mo ago | 81 | 2012 | Patrick Nef President & Chief Executive Officer | WordPressMySQLPHP+15 | — | — |
| 9 | Cynbiose Preclinical CRO specializing in the development of non-human primate models for enabling PoC studies | $2M | 81 mo ago | 21 | 2008 | — | WordPressMySQLPHP+21 | — | — |
| 10 | Meddenovo Developer of computational biochemistry software for pharmaceutical research and development | $1M | 27 mo ago | — | 2021 | Ilke Marion Co-Founder | — | — | — |
| 11 | Smartox Biotechnology Discovery and the synthesis of peptides coming from animal venoms and related drug discovery services | $1M | 37 mo ago | 14 | 2009 | Michel De Waard Founder | Cart FunctionalityWooCommerceWordPress+23 | — | — |
| 12 | Axplora Provider of contract based API products manufacturing services | $742K | 65 mo ago | 2,400 | 2018 | Sylke Hassel CEO | WordPressApple iCloud MailMySQL+17 | — | — |
| 13 | Voxcan 3D Imaging services for preclinical research | $426K | 130 mo ago | — | 2007 | — | — | — | — |
Top 12 Biopharma Outsourcing companies in Auvergne Rhone Alpes
#1
Series D · Meylan, Auvergne Rhone Alpes · founded 2003 · 12 employees$36.2Mraised▾
Provider of electronic clinical outcome assessment solutions for clinical trials. The company delivers a platform adaptable to protocol, population, and questionnaire requirements. It offers tools for data management, real-time data access, and in-depth analytics. The platform provides multiple data collection modes and patient engagement features. It also facilitates integration with other clinical systems to streamline data flow.
- Mar 2023Series D$2.4M
- Mar 2023Conventional Debt$3M
- Dec 2020Series D$8.4M
- Oct 2016Series C$4M
#2
Seed · Villeurbanne, Auvergne Rhone Alpes · founded 2021$1.1Mraised▾
Developer of computational biochemistry software for pharmaceutical research and development. The company specializes in cyclic peptides, creating solutions for novel drug research and development studies. It combines experience in the field with original software. The technology platform assists drug hunters in designing novel drug candidates through a combination of artificial intelligence and physical computational approaches.
- Jul 2024Seed$1.1M
#3
Seed · Saint Martin d Heres, Auvergne Rhone Alpes · founded 2009 · 14 employees$1.1Mraised▾
Smartox is specialized in investigating animal venom properties and manufacturing peptide toxins contained in venoms. It aims to discover innovative drugs from animal venoms. VenomScreen drug discovery services combine a compound library dedicated to HTS programs and hit-to-lead services. It offers a range of animal peptide toxins active on several membrane receptors including ion channels, GPCRs, and integrins. It also offers peptide synthesis service and drug discovery services. Smartox Biotechnology is a spin-off of Grenoble Institute of Neuroscience (partly owned by the University Joseph Fourier, Grenoble, France).
- Oct 2023Grant (prize money)$285.7K
- Mar 2017Seed$992.4K
#4
Series B · Archamps, Auvergne Rhone Alpes · founded 2012 · 81 employees$3.6Mraised▾
TransCure bio services have developed the Humanized Immune System (HIS) mouse model. The company offers these platforms as a service to pharmaceutical companies, biotechs as well as academic laboratories that profile new drugs targeting immune-related diseases and novel anti-HIV/AIDS therapies. They humanize immunodeficient strains by engrafting with hCD34 Hematopoietic stem cells (HSC) isolated from cord blood.
- Jun 2022Series B—
- Jun 2019Series A$2.8M
- Jun 2019Grant (prize money)$56K
- Aug 2014Seed$779.4K
#5
Acquired · Clermont Ferrand, Auvergne Rhone Alpes · founded 2013 · 2 employees$34.2Mraised▾
Biose is a provider of therapeutic macrobiotic ranges for human health. The company offers pharmaceutical laboratories and biotechs around the world a complete and integrated offer to carry out the entire production process of these drugs, from process development to production of finished products.
- Jul 2020Series C$34.2M
- Jan 2019Grant (prize money)$314.9K
#6
Late Stage · Aurillac, Auvergne Rhone Alpes · founded 1951 · 227 employees$34.2Mraised▾
Founded in 1951 by pharmacists and microbiologists, biose® has 60-year of experience in drug based on live bacteria, giving us a deep understanding of the entire process from discovery to registration. Focused on health through microbiota and microbiome science, we have specialised skills in the discovery, process development and manufacturing of Live Biotherapeutic Products (LBPs). We can develop your Drug substance and Drug product and manufacture at both clinical and commercial levels for your Live Biotherapeutic product. Fully GMP (pharma certified) we have expertise in both single and multi strain projects for AEROBIC and ANAEROBIC GMO or Non-GMO CAPSULES SACHETS TABLETS CREAMS & OILS
#7
Public · Lyon, Auvergne Rhone Alpes · founded 1999 · 124 employees$11.6Mraised▾
Genoway develops transgenic rodent models and customized cell lines. It uses homologous recombination, CRISPR/Cas, FLEX, TET, IRES Rosa 26/ Hprt to customize mouse and rat models, cellular models and mouse cell lines with knockout genes and point mutations according to research needs. Therapeutic area applications include neuroscience, immunology, metabolism, cardiovascular disorders, and cancer.
- Jan 2020Grant (prize money)$280.4K
- Feb 2016Grant (prize money)—
- Mar 2014Grant (prize money)$21.4K
- Sep 2004Series B$4.9M
#8
Acquired · Lyon, Auvergne Rhone Alpes · founded 2011 · 160 employees$54.8Mraised▾
ISALTIS, formed by the coming together of Bernardy and Givaudan Lavirotte (with a combined experience of 100 years of mineral-organic salts production), is a fine chemicals company engaged in the production of high purity mineral salts for the pharma, nutrition, personal care and chemical industries. They specialize in the synthesis of alkali and earth alkaline metals and others like Iron, Copper, Aluminium and Zinc. Their pharma market targeted products are used mainly as supplements to treat calcium, magnesium or iron deficiencies and they also offer high value-added actives as per customer's needs. The company exports over 80% of its products to 50+ countries.
- Mar 2015Series A$26.5M
- 2011Series A$28.3M
#9
Acquired · Lyon, Auvergne Rhone Alpes · founded 1995 · 798 employees$4Mraised▾
Novasep is a provider of chemical and biomolecule production and purification services that find their applications primarily in the pharmaceutical and biopharmaceutical industries. They also cater to industries such as fine chemicals, agro-chemicals, food & functional ingredients, and fermentation & chemical commodities. Their pharmaceutical services include CDMO services (early phase, kilo lab, late phase and commercial production) for APIs & Intermediates (Including Generics like Paclitaxel, Nitroglycerin), HPAPIs, Cytotoxics, and ADCs. The company's proprietary Prochrom® technology (a preparative and process scale HPLC solution) can be used for the separation and purification of APIs, synthetic peptides, oligonucleotides, recombinant proteins (including insulin), HPAPIs. Novasep's biopharmaceutical services cater to the development and manufacturing of Viruses & viral vectors, Biosafety Level 3 pathogens, Monoclonal antibodies & Recombinant proteins (mammalian, microbial and insect cell lines), and ADCs. The company also designs and supplies proprietary industrial purification systems for batch and continuous chromatography processes for biologics. The company has operations in
- Feb 2019Grant (prize money)$314.8K
- Mar 2012Series A$4M
#10
Acquired · Lyon, Auvergne Rhone Alpes · founded 1990 · 750 employees$8.4Mraised▾
Mapi Group is a provider of patient centric research services such as real world evidence, market access and health economics and outcomes research, real world strategy, and analytics, language services and strategic regulatory services (including pharmacovigilance) and global late phase research services. The company claims to have expertise in the design and conduct of post approval and commercialization programs for pharmaceuticals, biologics and medical devices. Mapi's research trust has more than 4000 COAs (Clinical Outcomes Assessments), 40,000 COA translations, and a research library with more than 29,000 COAs. The company claims to have expertise in rare diseases and gastrointestinal research. The company was acquired by ICON in 2017.
- Jun 2005PE$8.4M
#11
Seed · Marcy l Étoile, Auvergne Rhone Alpes · founded 2008 · 21 employees$2.1Mraised▾
Cynbiose offers exploratory and discovery platforms to study the efficacy and safety of new drugs in non-human primates to enable the conduct of Proof of Concept studies. Their exploratory platforms include the KineC 3 platform, to study the passage of CNS drugs across the blood-brain barrier and KineIA platform for the pharmacokinetic analysis of first- pass intestinal-liver metabolism effects of oral molecules. They have models to study the efficacy of drugs against neurodegenerative, inflammatory, infectious, cardiovascular and rheumatology (osteoarthritis) diseases. They are AAALAC accredited and use different in vivo imaging techniques. They claim to be backed by a network of partner companies, grouped within the French Association of Services and Innovation Companies for Life Sciences (AFSSI).
- Jan 2020Seed$2.1M
#12
Funding Raised · Lyon, Auvergne Rhone Alpes · founded 2018 · 2400 employees$742.2Kraised▾
Provider of contract based API products manufacturing services
- May 2021Grant (prize money)$742.2K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in France
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,220 France-affiliated papers.
- Centre National de la Recherche Scientifique280
- Inserm169
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement144
- Ministry of Agriculture118
- AgroParisTech36
- Gene3→26
- Genome2→14
- Antibody1→10
- Cell culture1→10
- Mutant1→10
- Gene2→30
- Agriculture1→20
- Selection (genetic algorithm)2→18
- Resistance (ecology)2→16
- Population1→12
- Agriculture2→13
- Antibiotic resistance3→12
- Population1→9
- Public health1→8
- Context (archaeology)2→9
Where biotechnology is researched across France
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in France
France biotechnology patent filing is cooling — 34,222 filings from 8,000 assignees (2016–2025), led by Centre NAT RECH Scient, INST NAT Sante RECH MED, Sanofi; annual filings 3501→2745.
- Centre NAT RECH Scient10040
- INST NAT Sante RECH MED8292
- Sanofi3990
- Pasteur Institut3416
- Agronomique INST NAT RECH1331
- Cellectis1320
- PF Medicament1203
- Commissariat Energie Atomique1151
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.